Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A pilot Peer Mentor intervention that trains Black MSM to use and promote uptake of HIV/STI self-testing to peers and sex partners.
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa
Mechanical Regulation of Selectin-Ligand Binding Kinetics
Nanoplatform-based combinational therapy against breast cancer
Investigational New Drug Toxicology Treat Alzheimer's
Recently added grants:
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network Study
Discovery and preclinical evaluation of Plasmodium falciparum and P. vivax coiled coil antigens for malaria vaccine development
Vaccine-mediated control of bacterial virulence regulation and infection
A novel protein export chaperone of Mycobacterium tuberculosis
Memory T Cell Cosigning Pathways in Sepsis-Induced Immune Dysregulation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095000-004
Application #
6828928
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant